Testing effectiveness (Phase 2)Ended earlyNCT01399593
What this trial is testing
Safety & Efficacy of Eculizumab to Prevent AMR in Living Donor Kidney Transplant Recipients Requiring Desensitization
Who this might be right for
Antibody Mediated Rejection
Alexion Pharmaceuticals, Inc. 102